INOVIO Pharmaceuticals Prices ~$17.5M Offering Of 12.5M Shares Of Common Stock And Warrants To Purchase Up To 12.5M Shares Of Common Stock, At A Combined Purchase Price Of $1.40/Share

4/2/2026
Impact: -50
Healthcare

INOVIO Pharmaceuticals, Inc. has announced a public offering of 12.5 million shares of common stock and accompanying warrants, priced at $1.40 per share, aiming to raise approximately $17.5 million in gross proceeds. The offering includes Series A and Series B warrants, each with an exercise price of $1.40 per share. All securities in the offering are being sold by INOVIO.

AI summary, not financial advice

Share: